000 | 01692 a2200481 4500 | ||
---|---|---|---|
005 | 20250514010007.0 | ||
264 | 0 | _c20010927 | |
008 | 200109s 0 0 eng d | ||
022 | _a0146-0404 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMurphy, C J | |
245 | 0 | 0 |
_aSpontaneous chronic corneal epithelial defects (SCCED) in dogs: clinical features, innervation, and effect of topical SP, with or without IGF-1. _h[electronic resource] |
260 |
_bInvestigative ophthalmology & visual science _cSep 2001 |
||
300 |
_a2252-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdministration, Topical |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCalcitonin Gene-Related Peptide _xmetabolism |
650 | 0 | 4 | _aChronic Disease |
650 | 0 | 4 |
_aCorneal Diseases _xdiagnosis |
650 | 0 | 4 |
_aDog Diseases _xdiagnosis |
650 | 0 | 4 | _aDogs |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aEpithelium, Corneal _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluorophotometry _xveterinary |
650 | 0 | 4 |
_aImmunoenzyme Techniques _xveterinary |
650 | 0 | 4 |
_aInsulin-Like Growth Factor I _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aSubstance P _xmetabolism |
650 | 0 | 4 |
_aThiolester Hydrolases _xmetabolism |
650 | 0 | 4 |
_aTrigeminal Nerve _xmetabolism |
650 | 0 | 4 |
_aTyrosine 3-Monooxygenase _xmetabolism |
650 | 0 | 4 | _aUbiquitin Thiolesterase |
650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xmetabolism |
700 | 1 | _aMarfurt, C F | |
700 | 1 | _aMcDermott, A | |
700 | 1 | _aBentley, E | |
700 | 1 | _aAbrams, G A | |
700 | 1 | _aReid, T W | |
700 | 1 | _aCampbell, S | |
773 | 0 |
_tInvestigative ophthalmology & visual science _gvol. 42 _gno. 10 _gp. 2252-61 |
|
999 |
_c11452035 _d11452035 |